Common use of Purchase Price; Number of Shares Clause in Contracts

Purchase Price; Number of Shares. (a) The registered holder of this Warrant (the “Holder”), commencing on the date hereof, is entitled upon surrender of this Warrant with the subscription form annexed hereto duly executed, at the principal office of the Company, to purchase from the Company, at a price per share of $2.80 (the “Purchase Price”), 185,714 fully paid and nonassessable shares of the Company’s Series D Preferred Stock, (the “Exercise Quantity”), $0.001 par value (the “Preferred Stock”).

Appears in 6 contracts

Samples: Secured Promissory Note (Fluidigm Corp), Loan and Security Agreement (Fluidigm Corp), Loan and Security Agreement (Fluidigm Corp)

AutoNDA by SimpleDocs

Purchase Price; Number of Shares. (a) The registered holder of this Warrant (the “Holder”)Warrant, commencing on the date hereof, is entitled upon surrender of this Warrant with the subscription form annexed hereto duly executed, at the principal office of the Company, to purchase from the Company, at a price per share of $2.80 1.655 (the “Purchase Price”), 185,714 302,114 fully paid and nonassessable shares of the Company’s Series D Preferred Stock, Stock (the “Exercise Quantity”), $0.001 par value Quantity (the “Preferred Stock”).

Appears in 3 contracts

Samples: Loan and Security Agreement (ARYx Therapeutics, Inc.), Loan and Security Agreement (ARYx Therapeutics, Inc.), ARYx Therapeutics, Inc.

Purchase Price; Number of Shares. (a) The registered holder of this Warrant (the "Holder"), commencing on the date hereof, is entitled upon surrender of this Warrant with the subscription form annexed hereto duly executed, at the principal office of the Company, to purchase from the Company, at a price per share of $2.80 1.73 (the "Purchase Price"), 185,714 up to a maximum of 300,578 fully paid and nonassessable shares of the Company’s 's Series D Preferred Stock, (the “Exercise Quantity”), $0.001 per share par value (the "Preferred Stock"). Commencing on the date hereof, 150,289 (the "Exercise Quantity") of shares of Preferred Stock are immediately available for purchase hereunder.

Appears in 3 contracts

Samples: Loan and Security Agreement (Anacor Pharmaceuticals Inc), Preferred Stock Purchase (Anacor Pharmaceuticals Inc), Preferred Stock Purchase (Anacor Pharmaceuticals Inc)

Purchase Price; Number of Shares. (a) The registered holder of this Warrant (the “Holder”), commencing on the date hereof, is entitled upon surrender of this Warrant with the subscription form annexed hereto duly executed, at the principal office of the Company, to purchase from the Company, at a price per share of $2.80 0.58 (the “Purchase Price”), 185,714 up to a maximum of 517,242 fully paid and nonassessable shares of the Company’s Series D B Convertible Preferred Stock, (the “Exercise Quantity”), $0.001 par value (the “Preferred Stock”). Commencing on the date hereof, 258,621 (the “Exercise Quantity”) of shares of Preferred Stock are immediately available for purchase hereunder.

Appears in 2 contracts

Samples: Registration Rights Agreement (Genocea Biosciences, Inc.), Registration Rights Agreement (Genocea Biosciences, Inc.)

Purchase Price; Number of Shares. (a) The registered holder of this Warrant (the “Holder”), commencing on the date hereof, is entitled upon surrender of this Warrant with the subscription form annexed hereto duly executed, at the principal office of the Company, to purchase from the Company, at a price per share of $2.80 1.00 (the “Purchase Price”), 185,714 up to a maximum of 200,000 fully paid and nonassessable shares of the Company’s Series D A Preferred Stock, (the “Exercise Quantity”), $0.001 0.0001 par value (the “Preferred Stock”). Commencing on the date hereof, 100,000 (the “Exercise Quantity”) of shares of Preferred Stock are immediately available for purchase hereunder.

Appears in 2 contracts

Samples: Loan and Security Agreement (Foundation Medicine, Inc.), Foundation Medicine, Inc.

Purchase Price; Number of Shares. (a) The registered holder of this Warrant (the “Holder”), commencing on the date hereof, is entitled upon surrender of this Warrant with the subscription form annexed hereto duly executed, at the principal office of the Company, to purchase from the Company, at a price per share of $2.80 0.85 (the “Purchase Price”), 185,714 (a) 88,235 fully paid and nonassessable shares of the Company’s Series D C Convertible Participating Preferred Stock, Stock (the “Exercise Quantity”), $0.001 par value (the “Preferred Stock”).

Appears in 2 contracts

Samples: Loan and Security Agreement (GlassHouse Technologies Inc), Loan and Security Agreement (GlassHouse Technologies Inc)

Purchase Price; Number of Shares. (a) The registered holder of this Warrant (the “Holder”), commencing on the date hereof, is entitled upon surrender of this Warrant with the subscription form annexed hereto duly executed, at the principal office of the Company, to purchase from the Company, at a price per share of $2.80 1.72 (the “Purchase Price”), 185,714 up to a maximum of 52,325 fully paid and nonassessable shares of the Company’s Series D A-l Preferred Stock, (the “Exercise Quantity”), $0.001 0.01 par value (the “Preferred Stock”). Commencing on the date hereof, 34,883 (the “Exercise Quantity”) of shares of Preferred Stock are immediately available for purchase hereunder.

Appears in 2 contracts

Samples: Care.com Inc, Care.com Inc

Purchase Price; Number of Shares. (a) The registered holder of this Warrant (the “Holder”), commencing on the date hereof, Holder is entitled upon surrender of this Warrant with the subscription form annexed hereto duly executed, at the principal office of the Company, to purchase purchase, on one or more occasions, in whole or in part, from the Company, at a price per share of $2.80 5.00 (the “Purchase Price”), 185,714 2,000,000 fully paid and nonassessable shares of the Company’s Series D Preferred Class A Common Stock, (the “Exercise Quantity”), $0.001 par value (the Preferred Class A Common Stock”).

Appears in 2 contracts

Samples: Security Agreement (Rent the Runway, Inc.), Rent the Runway, Inc.

Purchase Price; Number of Shares. (a) The registered holder of this Warrant (the "Holder"), commencing on the date hereof, is entitled upon surrender of this Warrant with the subscription form annexed hereto duly executed, at the principal office of the Company, to purchase from the Company, at a price per share of $2.80 0.475 (the "Purchase Price"), 185,714 11,875 fully paid and nonassessable shares of the Company’s Series D Preferred Stock, 's Common Stock (the "Exercise Quantity"), $0.001 par value (the “Preferred "Common Stock").

Appears in 2 contracts

Samples: Enernoc Inc, Enernoc Inc

Purchase Price; Number of Shares. (a) The registered holder of this Warrant (the "Holder"), commencing on the date hereof, is entitled upon surrender of this Warrant with the subscription form annexed hereto duly executed, at the principal office of the Company, to purchase from the Company, at a price per share of $2.80 0.84 (the "Purchase Price"), 185,714 238,095 fully paid and nonassessable shares (the "Exercise Quantity") of the Company’s 's Series D A Preferred Stock, Stock (the “Exercise Quantity”"Shares"), $0.001 par value (the "Preferred Stock").

Appears in 2 contracts

Samples: Loan and Security Agreement (NovaCardia Inc), NovaCardia Inc

Purchase Price; Number of Shares. (a) The registered holder of this Warrant (the “Holder”), commencing on the date hereof, is entitled upon surrender of this Warrant with the subscription form annexed hereto duly executed, at the principal office of the Company, to purchase from the Company, at a price per share of $2.80 4.00 (the “Purchase Price”), 185,714 100,000 fully paid and nonassessable shares of the Company’s Series D E Preferred Stock, (the “Exercise Quantity”), $0.001 par value (the “Preferred Stock”).

Appears in 2 contracts

Samples: Secured Promissory Note (Fluidigm Corp), Loan and Security Agreement (Fluidigm Corp)

Purchase Price; Number of Shares. (a) The registered holder of this Warrant (the “Holder”), commencing on the date hereof, is entitled upon surrender of this Warrant with the subscription form annexed hereto duly executed, at the principal office of the Company, to purchase from the Company, at a price per share of $2.80 (equal to the Purchase Price”), 185,714 that number of fully paid and nonassessable shares of the Company’s Series D Preferred Stock, (Next Round Stock equal to $539,000 divided by the “Exercise Quantity”), $0.001 par value (the “Preferred Stock”)Purchase Price.

Appears in 1 contract

Samples: Kior Inc

Purchase Price; Number of Shares. (a) The registered holder of this Warrant (the “Holder”"HOLDER"), commencing on the date hereof, is entitled upon surrender of this Warrant with the subscription form annexed hereto duly executed, at the principal office of the Company, to purchase from the Company, at a price per share of $2.80 3.8558 (the “Purchase Price”"PURCHASE PRICE"), 185,714 45,386 fully paid and nonassessable shares of the Company’s 's Series D Convertible Preferred Stock, Stock (the “Exercise Quantity”"EXERCISE QUANTITY"), $0.001 par value per share (the “Preferred Stock”"PREFERRED STOCK").

Appears in 1 contract

Samples: Loan and Security Agreement (Combinatorx, Inc)

Purchase Price; Number of Shares. (a) The registered holder of this Warrant (the “Holder”), commencing on the date hereof, is entitled upon surrender of this Warrant with the subscription form annexed hereto duly executed, at the principal office of the Company, to purchase from the Company, at a price per share of $2.80 5.2581 (the “Purchase Price”), 185,714 up to a maximum of 228,219 fully paid and nonassessable shares of the Company’s Series D Preferred Stock, (the “Exercise Quantity”), $0.001 0.00001 par value (the “Preferred Stock”). Commencing on the date hereof, 114,109 (the “Exercise Quantity”) of shares of Preferred Stock are immediately available for purchase hereunder.

Appears in 1 contract

Samples: Kythera Biopharmaceuticals Inc

Purchase Price; Number of Shares. (a) The registered holder of this Warrant (the “Holder”), commencing on the date hereof, is entitled upon surrender of this Warrant with the subscription form annexed hereto duly executed, at the principal office of the Company, to purchase from the Company, at a price per share of $2.80 2.33 (the “Purchase Price”), 185,714 up to a maximum of 15,021 fully paid and nonassessable shares of the Company’s Series D A-4 Preferred Stock, (the “Exercise Quantity”), $0.001 0.01 par value (the “Preferred Stock”). Commencing on the date hereof, 8,583 (the “Exercise Quantity”) of shares of Preferred Stock are immediately available for purchase hereunder.

Appears in 1 contract

Samples: Gevo, Inc.

Purchase Price; Number of Shares. (a) The registered holder of this Warrant (the “Holder”), commencing on the date hereof, is entitled upon surrender of this Warrant with the subscription form annexed hereto duly executed, at the principal office of the Company, to purchase from the Company, at a price per share of $2.80 8.65 (the “Purchase Price”), 185,714 up to a maximum of 97,109 fully paid and nonassessable shares of the Company’s Series D Preferred Common Stock, (the “Exercise Quantity”), $0.001 per share par value (the “Preferred Common Stock”).

Appears in 1 contract

Samples: Anacor Pharmaceuticals, Inc.

Purchase Price; Number of Shares. (a) The registered holder of this Warrant (the “Holder”), commencing on the date hereof, is entitled upon surrender of this Warrant with the subscription form annexed hereto duly executed, at the principal office of the Company, to purchase from the Company, at a price per share of $2.80 (equal to the Purchase Price”), 185,714 that number of fully paid and nonassessable shares of the Company’s Series D Preferred Stock, (Next Round Stock equal to $231,000 divided by the “Exercise Quantity”), $0.001 par value (the “Preferred Stock”)Purchase Price.

Appears in 1 contract

Samples: Kior Inc

AutoNDA by SimpleDocs

Purchase Price; Number of Shares. (a) The registered holder of this Warrant (the "Holder"), commencing on the date hereof, is entitled upon surrender of this Warrant with the subscription form annexed hereto duly executed, at the principal office of the Company, to purchase from the Company, at a price per share of $2.80 1.73 (the "Purchase Price"), 185,714 up to a maximum of 485,548 fully paid and nonassessable shares of the Company’s 's Series D Preferred Stock, (the “Exercise Quantity”), $0.001 per share par value (the "Preferred Stock"). Commencing on the date hereof, 323,699 (the "Exercise Quantity") of shares of Preferred Stock are immediately available for purchase hereunder.

Appears in 1 contract

Samples: Anacor Pharmaceuticals Inc

Purchase Price; Number of Shares. (a) The registered holder of this Warrant (the “Holder”), commencing on the date hereof, is entitled upon surrender of this Warrant with the subscription form or Net Issuance Election Notice form annexed hereto duly executed, at the principal office of the Company, to purchase from the Company, at a price per share of $2.80 3.37 (the “Series D Purchase Price”), 185,714 111,274 (the “Exercise Quantity”) of fully paid and nonassessable shares of the Company’s Series D Preferred Stock, (the “Exercise Quantity”), $0.001 0.0001 par value per share (the “Preferred Stock”).

Appears in 1 contract

Samples: Preferred Stock Warrant Agreement (Zoosk, Inc)

Purchase Price; Number of Shares. (a) The Subject to the terms and conditions hereinafter set forth, the registered holder of this Warrant (the "Holder”), commencing on the date hereof, ") is entitled upon surrender of this Warrant with the subscription form annexed hereto hereto, duly executed, at the principal office of the Company, to purchase from 9,457 shares of common stock of the Company, at a price par value $.01 per share (the "Common Stock"), at the per share exercise price of $2.80 2.24 (the "Purchase Price”), 185,714 fully paid and nonassessable shares of the Company’s Series D Preferred Stock, (the “Exercise Quantity”), $0.001 par value (the “Preferred Stock”").

Appears in 1 contract

Samples: Edison Venture Fund Ii Lp

Purchase Price; Number of Shares. (a) The registered holder of this Warrant (the “Holder”), commencing on the date hereof, is entitled upon surrender of this Warrant with the subscription form annexed hereto duly executed, at the principal office of the Company, to purchase from the Company, at a price per share of $2.80 5.48 (the “Purchase Price”), 185,714 up to a maximum of 27,372 fully paid and nonassessable shares of the Company’s Series D C Preferred Stock, (the “Exercise Quantity”), $0.001 0.01 par value (the “Preferred Stock”). Commencing on the date hereof, 16,423 (the “Exercise Quantity”) of shares of Preferred Stock are immediately available for purchase hereunder.

Appears in 1 contract

Samples: Rights Agreement (Gevo, Inc.)

Purchase Price; Number of Shares. (a) The registered holder of this Warrant (the “Holder”), commencing on the date hereof, is entitled upon surrender of this Warrant with the subscription form annexed hereto duly executed, at the principal office of the Company, to purchase from the Companycompany, at a price per share of $2.80 5.48 (the “Purchase Price”), 185,714 up to a maximum of 59,307 fully paid and nonassessable shares of the Company’s Series D C Preferred Stock, (the “Exercise Quantity”), $0.001 0.01 par value (the “Preferred Stock”). Commencing on the date hereof, 45,620 (the “Exercise Quantity”) of shares of Preferred Stock are immediately available for purchase hereunder.

Appears in 1 contract

Samples: Rights Agreement (Gevo, Inc.)

Purchase Price; Number of Shares. (a) The registered holder of this Warrant (the “Holder”), commencing on the date hereof, is entitled upon surrender of this Warrant with the subscription form annexed hereto duly executed, at the principal office of the Company, to purchase from the Company, at a price per share of $2.80 0.9304 (the “Purchase Price”), 185,714 up to a maximum of 271,221 fully paid and nonassessable shares of the Company’s Series D B Preferred Stock, (the “Exercise Quantity”), $0.001 par value (the “Preferred Stock”). Commencing on the date hereof, 110,000 (the “Exercise Quantity”) of shares of Preferred Stock are immediately available for purchase hereunder.

Appears in 1 contract

Samples: Invuity, Inc.

Purchase Price; Number of Shares. (a) The registered holder of this Warrant (the “Holder”), commencing on the date hereof, is entitled upon surrender of this Warrant with the subscription form annexed hereto duly executed, at the principal office of the Company, to purchase from the Company, at a price per share of $2.80 0.83 (the “Purchase Price”), 185,714 up to a maximum of 963,856 fully paid and nonassessable non-assessable shares of the Company’s Series D Convertible Preferred Stock, (the “Exercise Quantity”), $0.001 0.01 par value (the “Preferred Stock”). Commencing on the date hereof, 421,687 (the “Exercise Quantity”) of shares of Preferred Stock are immediately available for purchase hereunder.

Appears in 1 contract

Samples: Cerulean Pharma Inc.

Purchase Price; Number of Shares. (a) The registered holder of this Warrant (the “Holder”), commencing on the date hereof, is entitled upon surrender of this Warrant with the subscription form annexed hereto duly executed, at the principal office of the Company, to purchase from the Company, at a price per share of $2.80 1.75 (the “Purchase Price”), 185,714 up to a maximum of 15,000 fully paid and nonassessable shares of the Company’s Series D A-3 Preferred Stock, (the “Exercise Quantity”), $0.001 0.01 par value (the “Preferred Stock”). Commencing on the date hereof, 8,571 (the “Exercise Quantity”) of shares of Preferred Stock are immediately available for purchase hereunder.

Appears in 1 contract

Samples: Preferred Stock Warrant Agreement (Gevo, Inc.)

Purchase Price; Number of Shares. (a) The registered holder of this Warrant (the “Holder”), commencing on the date hereof, is entitled upon surrender of this Warrant with the subscription form annexed hereto duly executed, at the principal office of the Company, to purchase from the Company, at a price per share of $2.80 4.80446 (the “Purchase Price”), 185,714 up to a maximum of 499,535 fully paid and nonassessable shares of the Company’s Series D E Preferred Stock, (the “Exercise Quantity”), $0.001 par value (the “Preferred Stock”). Commencing on the date hereof, 333,023 (the “Exercise Quantity”) of shares of Preferred Stock are immediately available for purchase hereunder.

Appears in 1 contract

Samples: SuccessFactors, Inc.

Purchase Price; Number of Shares. (a) The registered holder of this Warrant (the "Holder"), commencing on the date hereof, is entitled upon surrender of this Warrant with the subscription form annexed hereto duly executed, at the principal office of the Company, to purchase from the Company, at a price per share of $2.80 1.125 (the "Purchase Price"), 185,714 up to a maximum of 933,333 fully paid and nonassessable shares of the Company’s 's Series D B Preferred Stock, Stock (the “Exercise Quantity”"Shares"), $0.001 par value (the "Preferred Stock").. Commencing on the date hereof, 533,333 (the "Exercise Quantity") of shares of Preferred Stock are immediately available for purchase hereunder

Appears in 1 contract

Samples: NovaCardia Inc

Purchase Price; Number of Shares. (a) The registered holder of this Warrant (the “Holder”), commencing on the date hereof, is entitled upon surrender of this Warrant with the subscription form annexed hereto duly executed, at the principal office of the Company, to purchase from the Company, at a price per share of $2.80 5.0497 (the “Purchase Price”), 185,714 up to a maximum of 237,638 fully paid and nonassessable shares of the Company’s Series D C Preferred Stock, (the “Exercise Quantity”), $0.001 0.00001 par value (the “Preferred Stock”). Commencing on the date hereof, 89,114 (the “Exercise Quantity”) of shares of Preferred Stock are immediately available for purchase hereunder.

Appears in 1 contract

Samples: Preferred Stock Purchase Warrant (Kythera Biopharmaceuticals Inc)

Time is Money Join Law Insider Premium to draft better contracts faster.